Precigen Earnings
NASDAQ: PGENHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.81+0.21 (+2.76%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Precigen earnings summary
In its most recent report on Aug 4, 2026 (Q2 2026), PGEN posted EPS of $0.05. Revenue for the quarter was $55.0 million. Across the last 16 reports, PGEN shares moved an average of 10.6% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
PGEN earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 4, 2026 | — | $0.05 | — | -15.6% |
| May 13, 2026 | — | $-0.02 | — | -4.1% |
| Mar 25, 2026 | — | $-0.04 | — | +7.4% |
| Nov 13, 2025 | — | $-1.06 | — | -20.0% |
| Aug 12, 2025 | — | $-0.09 | — | +42.2% |
| May 14, 2025 | — | $-0.18 | — | -5.5% |
| Mar 19, 2025 | — | $-0.05 | — | -12.2% |
| Nov 14, 2024 | — | $-0.09 | — | +9.8% |
| Aug 6, 2024 | — | $-0.23 | — | -0.9% |
| May 14, 2024 | — | $-0.10 | — | -1.4% |
| Mar 19, 2024 | — | $-0.13 | — | +3.6% |
| Nov 9, 2023 | — | $-0.08 | — | +8.3% |
| Aug 9, 2023 | — | $-0.08 | — | +4.5% |
| May 10, 2023 | — | $-0.10 | — | +21.7% |
| Mar 6, 2023 | — | $-0.11 | — | -6.4% |
| Nov 9, 2022 | — | $0.44 | — | +6.5% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.